Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0278126 (
loss of equilibrium
)
140
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gynecomastia
is a benign, abnormal, growth of the male breast gland which can occur unilaterally or bilaterally, resulting from a proliferation of glandular, fibrous and adipose tissue.
Gynecomastia
is characterised by the presence of soft, 2-4 cm in diameter, usually discusshaped enlargement of tissues under the nipple. It is estimated that this pathology occurs in 32-65% of men over the age of 17.
Gynecomastia
is a psychosocial problem and may lead to a perceived lowering of quality of life. The main cause of
gynecomastia
is a
loss of equilibrium
between oestrogens and androgens. Increased sensitivity for oestrogens of the breast gland, or local factors (e.g. an excessive synthesis of oestrogens in breast tissues or changes in oestrogen and androgen receptors) may cause
gynecomastia
. Also, prolactin, thyroxine, cortisol, human chorionic gonadotropin, leptin and receptors for human chorionic gonadotropin, prolactin and luteinizing hormone localised in tissues of the male breast may participate in the etiopathogenesis of
gynecomastia
. Usually three types of
gynecomastia
are distinguished: physiological, idiopathic and pathological
gynecomastia
. The latter is the consequence of relative or absolute excess of oestrogens. In this paper, frequent as well as casuistic causes of
gynecomastia
will be described. A diagnosis of
gynecomastia
is usually possible after a palpation examination. Ultrasonographic, mammographic or histopathological examinations are useful in aiding diagnosis. The five degree scale devised by Tanner and Marshall is useful in estimating disease progression.
...
PMID:Gynecomastia - a difficult diagnostic problem. 2152 84